HPV-associated head and neck cancer: a virus-related cancer epidemic.

[1]  J. Taube,et al.  Inverse Relationship between Human Papillomavirus-16 Infection and Disruptive p53 Gene Mutations in Squamous Cell Carcinoma of the Head and Neck , 2008, Clinical Cancer Research.

[2]  W. Westra,et al.  Oral Human Papillomavirus Infection Before and After Treatment for Human Papillomavirus 16–Positive and Human Papillomavirus 16–Negative Head and Neck Squamous Cell Carcinoma , 2008, Clinical Cancer Research.

[3]  J. Tortochaux,et al.  Cancers de l'oropharynx de stades III et IV : résultats d'une étude randomisée du Gortec comparant radiothérapie exclusive et radiothérapie avec chimiothérapie concomitante , 2000 .

[4]  S. Coughlin,et al.  Burden of potentially human papillomavirus‐associated cancers of the oropharynx and oral cavity in the US, 1998–2003 , 2008, Cancer.

[5]  S. El-Mofty,et al.  Detection of human papillomavirus‐related squamous cell carcinoma cytologically and by in situ hybridization in fine‐needle aspiration biopsies of cervical metastasis , 2008, Cancer.

[6]  K. Shah,et al.  Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus. , 2004, The Journal of infectious diseases.

[7]  C. Tsien,et al.  EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  T. Sveinsson,et al.  [Head and neck squamous cell cancer]. , 2009, Laeknabladid.

[9]  W. Westra,et al.  Detection of Human Papillomavirus-16 in Fine-Needle Aspirates to Determine Tumor Origin in Patients with Metastatic Squamous Cell Carcinoma of the Head and Neck , 2007, Clinical Cancer Research.

[10]  D. Sidransky,et al.  Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. , 2000, Journal of the National Cancer Institute.

[11]  Lu-Ting Kuo,et al.  The biomarkers of human papillomavirus infection in tonsillar squamous cell carcinoma—molecular basis and predicting favorable outcome , 2008, Modern Pathology.

[12]  D. Sidransky,et al.  Detection and quantitation of human papillomavirus (HPV) DNA in the sera of patients with HPV-associated head and neck squamous cell carcinoma. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[13]  W. Westra,et al.  Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. , 2008, Journal of the National Cancer Institute.

[14]  K. Shah,et al.  Detection of human papillomavirus in cervical lymph nodes: a highly effective strategy for localizing site of tumor origin. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[15]  C. Tsien,et al.  Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  K. Kelsey,et al.  Lack of association of alcohol and tobacco with HPV16-associated head and neck cancer. , 2007, Journal of the National Cancer Institute.

[17]  L. Turek,et al.  Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. , 2003, Journal of the National Cancer Institute.

[18]  C. R. Leemans,et al.  A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen , 2007, International journal of cancer.

[19]  E. Speel,et al.  Marked differences in survival rate between smokers and nonsmokers with HPV 16‐associated tonsillar carcinomas , 2008, International journal of cancer.

[20]  C. R. Leemans,et al.  Oral and oropharyngeal cancer in The Netherlands between 1989 and 2006: Increasing incidence, but not in young adults. , 2009, Oral oncology.

[21]  G. Calais,et al.  Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  M. Irigoyen-Camacho,et al.  High association of human papillomavirus infection with oral cancer: a case-control study. , 2008, Archives of medical research.

[23]  F. Bosch,et al.  Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. , 1998, Cancer research.

[24]  S. Schwartz,et al.  Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. , 1998, Journal of the National Cancer Institute.

[25]  H. Dienes,et al.  Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas , 2001, Cancer.

[26]  B. Hansson,et al.  Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: A population-based case-control study in southern Sweden , 2005, Acta oto-laryngologica.

[27]  A. Eisbruch,et al.  Association of tobacco (T) use with risk of distant metastases (DM), tumor recurrence, and death in patients (pts) with HPV-positive (+) squamous cell cancer of the oropharynx (SCCOP). , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  L. Turek,et al.  Human papillomavirus and risk of oral cancer , 1998, The Laryngoscope.

[29]  J. Laissue,et al.  Human papillomavirus positive squamous cell carcinoma of the oropharynx , 2001, Cancer.

[30]  F. Hoppe-Seyler,et al.  Cellular responses of HPV‐positive cancer cells to genotoxic anti‐cancer agents: Repression of E6/E7‐oncogene expression and induction of apoptosis , 1996, International journal of cancer.

[31]  Carole Fakhry,et al.  Case-control study of human papillomavirus and oropharyngeal cancer. , 2007, The New England journal of medicine.

[32]  D. Sidransky,et al.  Head and Neck Cancer in CNonsmokers: A Distinct Clinical and Molecular Entity , 1999, The Laryngoscope.

[33]  Fabrice Denis,et al.  Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systems. , 2003, International journal of radiation oncology, biology, physics.

[34]  Steven S. Chang,et al.  Presence of HPV DNA in convalescent salivary rinses is an adverse prognostic marker in head and neck squamous cell carcinoma. , 2008, Oral oncology.

[35]  G. Elmberger,et al.  P16(INK4a) correlates to human papillomavirus presence, response to radiotherapy and clinical outcome in tonsillar carcinoma. , 2005, Anticancer research.

[36]  E. Munck‐Wikland,et al.  Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer , 2006, International journal of cancer.

[37]  B. Schmidt,et al.  Tongue and tonsil carcinoma , 2005, Cancer.

[38]  D. Lindquist,et al.  The incidence of tonsillar cancer in Sweden is increasing , 2007, Acta oto-laryngologica.

[39]  P. Arapantoni-Dadioti,et al.  Human papillomavirus frequency in oral and oropharyngeal cancer in Greece. , 2008, Anticancer research.

[40]  J. Pintos,et al.  Human papillomavirus infection and oral cancer: a case-control study in Montreal, Canada. , 2008, Oral oncology.

[41]  M. Pawlita,et al.  Human papillomavirus seropositivity and risks of head and neck cancer , 2007, International journal of cancer.

[42]  G. Ogden,et al.  Incidence of oral and oropharyngeal cancer in United Kingdom (1990-1999) -- recent trends and regional variation. , 2006, Oral oncology.

[43]  G. Macfarlane,et al.  Oropharyngeal cancer incidence and mortality in Scotland: are rates still increasing? , 2003, Oral oncology.

[44]  W. Westra,et al.  Bcl-2 Blocks Cisplatin-Induced Apoptosis and Predicts Poor Outcome Following Chemoradiation Treatment in Advanced Oropharyngeal Squamous Cell Carcinoma , 2009, Clinical Cancer Research.

[45]  A. Carvalho,et al.  Feasibility of quantitative PCR‐based saliva rinse screening of HPV for head and neck cancer , 2005, International journal of cancer.

[46]  B. Herman,et al.  Human papillomavirus type 16 E6 and HPV‐16 E6/E7 sensitize human keratinocytes to apoptosis induced by chemotherapeutic agents: Roles of p53 and caspase activation , 2000, Journal of cellular biochemistry.

[47]  P. Sparén,et al.  Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: An epidemic of viral‐induced carcinoma? , 2009, International journal of cancer.

[48]  A. Cmelak,et al.  Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. , 2008, Journal of the National Cancer Institute.

[49]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[50]  A. Russo,et al.  HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies: a meta-analysis (1988-2007). , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[51]  E. Munck‐Wikland,et al.  Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7 , 2007, Molecular oncology.

[52]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[53]  G. Calais,et al.  [Stage III and IV cancers of the oropharynx: results of a randomized study of Gortec comparing radiotherapy alone with concomitant chemotherapy]. , 2000, Bulletin du cancer.

[54]  A. Giuliano,et al.  HEAD AND NECK SQUAMOUS CELL CANCER AND THE HUMAN PAPILLOMAVIRUS: SUMMARY OF A NATIONAL CANCER INSTITUTE STATE OF THE SCIENCE MEETING, , 2009 .

[55]  Y. Agrawal,et al.  Oral sexual behaviors associated with prevalent oral human papillomavirus infection. , 2009, The Journal of infectious diseases.

[56]  B. Levy,et al.  Human papillomavirus in the oral cavities of children and adolescents. , 2001, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[57]  L. Turek,et al.  Prevalence of Human Papillomavirus in the Oral Cavity/Oropharynx in a Large Population of Children and Adolescents , 2007, The Pediatric infectious disease journal.

[58]  W. Westra,et al.  Basaloid Squamous Cell Carcinoma of the Head and Neck is a Mixed Variant That Can be Further Resolved by HPV Status , 2008, The American journal of surgical pathology.

[59]  J. Califano,et al.  Cystic lymph node metastasis in patients with head and neck cancer: An HPV‐associated phenomenon , 2008, Head & neck.

[60]  K. Anastos,et al.  Six‐month natural history of oral versus cervical human papillomavirus infection , 2007, International journal of cancer.

[61]  L. Turek,et al.  Does Pretreatment Seropositivity to Human Papillomavirus Have Prognostic Significance for Head and Neck Cancers? , 2008, Cancer Epidemiology Biomarkers & Prevention.

[62]  W. Westra,et al.  Molecular pathology of head and neck cancer: implications for diagnosis, prognosis, and treatment. , 2009, Annual review of pathology.

[63]  J. Dahm-Daphi.  p53: Biology and Role for Cellular Radiosensitivity , 2000, Strahlentherapie und Onkologie.

[64]  L. Turek,et al.  Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers , 2004, International journal of cancer.

[65]  A. Chaturvedi,et al.  Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[66]  C. Chung,et al.  Survival outcomes by tumor human papillomavirus (HPV) status in stage III-IV oropharyngeal cancer (OPC) in RTOG 0129. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[67]  J. Brandsma,et al.  Association of papillomavirus with cancers of the head and neck. , 1989, Archives of otolaryngology--head & neck surgery.

[68]  F. X. Bosch,et al.  Epidemiologic classification of human papillomavirus types associated with cervical cancer. , 2003, The New England journal of medicine.

[69]  Yunping Lu 卢运萍,et al.  Apoptosis of HeLa cells induced by cisplatin and its mechanism , 2008, Journal of Huazhong University of Science and Technology [Medical Sciences].

[70]  R. Fisher,et al.  Prognostic significance of HPV and p16 status in patients with oropharyngeal cancer treated on a large international phase III trial. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[71]  R. Bristow,et al.  The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy. , 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[72]  R. Kodet,et al.  Demographic and risk factors in patients with head and neck tumors , 2009, Journal of medical virology.

[73]  Christine H Chung,et al.  Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[74]  F. Bosch,et al.  Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control , 2002, Oncogene.

[75]  M. Zahurak,et al.  Tissue Distribution of Human Papillomavirus 16 DNA Integration in Patients with Tonsillar Carcinoma , 2005, Clinical Cancer Research.

[76]  A. Giuliano,et al.  Head and neck squamous cell cancer and the human papillomavirus: Summary of a National Cancer Institute State of the Science Meeting, November 9–10, 2008, Washington, D.C. , 2009, Head & neck.

[77]  S. Franceschi,et al.  Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review , 2005, Cancer Epidemiology Biomarkers & Prevention.